144 related articles for article (PubMed ID: 38090708)
1. Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy.
Kaltenboeck A; Foerster E; Strafner S; Demal U; Mossaheb N; Friedrich F
Front Psychiatry; 2023; 14():1291077. PubMed ID: 38090708
[TBL] [Abstract][Full Text] [Related]
2. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
[TBL] [Abstract][Full Text] [Related]
3. [Combination of ketamine and esketamine with Exposure and Response Prevention (ERP) therapy for Obsessive-Compulsive Disorder].
Bottemanne H; Arnould A; Najar A; Delaigue F; Serresse L; Joly L; Mouchabac S
Encephale; 2023 Jun; 49(3):304-311. PubMed ID: 37095049
[TBL] [Abstract][Full Text] [Related]
4. The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report.
Matteo M; Cristian P; Laura M; Federico M; Chiara R; Lorenzo G; Michaela K; Sibilla M; Roberto N; Fabrizia C; Antonios D; Alice C; Enrico C; Beatrice B; Francesca B; Nicoletta V; Alberto P; Silvia I; Massimo C
Ann Gen Psychiatry; 2021 Sep; 20(1):43. PubMed ID: 34530843
[TBL] [Abstract][Full Text] [Related]
5. Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Shannahoff-Khalsa D; Fernandes RY; Pereira CAB; March JS; Leckman JF; Golshan S; Vieira MSR; Polanczyk GV; Miguel EC; Shavitt RG
Front Psychiatry; 2019; 10():793. PubMed ID: 31780963
[No Abstract] [Full Text] [Related]
6. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.
Martinotti G; Chiappini S; Pettorruso M; Mosca A; Miuli A; Di Carlo F; D'Andrea G; Collevecchio R; Di Muzio I; Sensi SL; Di Giannantonio M
Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34199023
[TBL] [Abstract][Full Text] [Related]
8. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
[TBL] [Abstract][Full Text] [Related]
10. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
Foa EB; Simpson HB; Rosenfield D; Liebowitz MR; Cahill SP; Huppert JD; Bender J; McLean CP; Maher MJ; Campeas R; Hahn CG; Imms P; Pinto A; Powers MB; Rodriguez CI; Van Meter PE; Vermes D; Williams MT
J Clin Psychiatry; 2015 Apr; 76(4):440-6. PubMed ID: 25375780
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review.
Ferguson AA; Khan AI; Abuzainah B; Chaudhuri D; Khan KI; Al Shouli R; Allakky A; Hamdan JA
Cureus; 2023 Apr; 15(4):e37833. PubMed ID: 37213965
[TBL] [Abstract][Full Text] [Related]
12. Serotonin reuptake inhibitor-cognitive behavioural therapy-second generation antipsychotic combination for severe treatment-resistant obsessive-compulsive disorder. A prospective observational study.
Tundo A; Salvati L; Cieri L; Balestrini V; Di Spigno D; Orazi F; Iommi M; Necci R
Int J Psychiatry Clin Pract; 2022 Nov; 26(4):395-400. PubMed ID: 35323098
[TBL] [Abstract][Full Text] [Related]
13. Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes From a Retrospective Longitudinal Observational Study.
Feusner JD; Farrell NR; Kreyling J; McGrath PB; Rhode A; Faneuff T; Lonsway S; Mohideen R; Jurich JE; Trusky L; Smith SM
J Med Internet Res; 2022 May; 24(5):e36431. PubMed ID: 35587365
[TBL] [Abstract][Full Text] [Related]
14. Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.
Alves-Pereira R; Fontes M; Cordeiro V; Bandeira ID; Faria-Guimarães D; Silva SS; Mello RP; Leal GC; Sampaio AS; Quarantini LC
Clin Neuropharmacol; 2024 Jan-Feb 01; 47(1):17-21. PubMed ID: 38194244
[TBL] [Abstract][Full Text] [Related]
15. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
[TBL] [Abstract][Full Text] [Related]
17. Internet-based cognitive behavioral therapy in children and adolescents with obsessive-compulsive disorder: A randomized controlled trial.
Hollmann K; Hohnecker CS; Haigis A; Alt AK; Kühnhausen J; Pascher A; Wörz U; App R; Lautenbacher H; Renner TJ; Conzelmann A
Front Psychiatry; 2022; 13():989550. PubMed ID: 36329915
[TBL] [Abstract][Full Text] [Related]
18. Ketamine Infusion in a Resistant Obsessive-Compulsive Disorder Patient in Bangladesh with Severe Suicidal Ideation: A Case Report.
Algin S; Banik D; Rahman SA; Mahmud Tusher S; Tuj Johora F; Akter A; Ahmed T; Biswas MAM; Sinha S; Haque M
Cureus; 2024 Apr; 16(4):e57877. PubMed ID: 38596207
[TBL] [Abstract][Full Text] [Related]
19. The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder.
Sampaio T; Lima C; Corregiari F; Bernik M
Braz J Psychiatry; 2016; 38(4):287-293. PubMed ID: 27798711
[TBL] [Abstract][Full Text] [Related]
20. The Suitability of Different Subtypes and Dimensions of Obsessive-Compulsive Disorder for Treatment with Anterior Capsulotomy: A Long-Term Follow-Up Study.
Gong F; Li B; Zhang S; Wang Y; Gao Y; Xu Y; Wang X; Xiong B; Li D; Wen R; Qin Z; Wang W
Stereotact Funct Neurosurg; 2019; 97(5-6):319-336. PubMed ID: 31786574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
